Afleveringen
-
Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO, sits down with Sonya Malekzadeh, MD, leader of the AAO-HNSF Otolaryngology Core Curriculum Editorial Board, Past Board member, Past Coordinator of Education, and Past Women in Otolaryngology Section Chair, during the November 2024 SUO/AADO/OPDO Meeting to discuss Dr. Malekzadeh's multi parallel paths in the Academy and her tenacity to see a need and fill it with engagement and leadership.
-
Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO, spent some time in the field with AAO-HNS/F Board member Marc Dubin, MD, at his practice in Baltimore, Maryland, The Centers for Advanced ENT Care, discussing the journey and evolution of private practice and patient care in today's healthcare climate. Dr. Dubin has evolved his practice, those of his 17 colleagues' practices, and since 2023, has been strategically aligned with ENT Specialty Partners. Engage in the discussion, listen/watch now, and look for more on this topic at the 2025 OTO Forum.
Join the conversation on ENT Connect: https://entconnect.entnet.org/home
-
Zijn er afleveringen die ontbreken?
-
AAO-HNS/F President Troy D. Woodard, MD, joins AAO-HNS/F Executive Vice President and CEO Rahul K. Shah, MD, MBA, for this Voices of Otolaryngology episode, which was recorded during Dr. Woodard's visit to Academy headquarters on December 10, 2024. Dr. Woodard shares his personal journey to otolaryngology; insight into his practice at Cleveland Clinic; his philosophical approach to balance, inclusion, mentorship, and wellness; why the Academy plays an essential role in the success of our specialty; the process for the upcoming strategic plan update; and so much more!
Helpful Resources:
Scroll to the bottom of the BOG webpage to access the Legislative Affairs Toolkit and other resources: https://www.entnet.org/get-involved/board-of-governors/Note: Contributions to ENT PAC are not deductible as charitable contributions for federal income tax purposes. Contributions are voluntary, and all members of the American Academy of Otolaryngology–Head and Neck Surgery have the right to refuse to contribution without reprisal. Federal law prohibits ENT PAC from accepting contributions from foreign nationals. By law, if your contributions are made using a personal check or credit card, ENT PAC may use your contribution only to support candidates in federal elections. All corporate contributions to ENT PAC will be used for educational and administrative fees of ENT PAC, and other activities permissible under federal law. Federal law requires ENT PAC use its best efforts to collect and report the name, mailing address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year. ENT PAC is a program of the AAO-HNS which is exempt from federal income tax under section 501 (c) (6) of the Internal Revenue Code.
-
Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO, is joined by Cristina M. Baldassari, MD, Board of Governors (BOG) Chair, Lance A. Manning, MD, AAO-HNS Advocacy Coordinator, Eileen M. Raynor, MD, BOG Legislative Affairs Committee Chair, and Matthew D. Scarlett, MD, ENT PAC Chair, to discuss the vital role that advocacy plays in the Academy to support members in their practice and patient care. The group also talks about the crucial need for more member involvement in strengthening the voice of otolaryngology and how individuals can get engaged and make a difference.
Helpful Resources:
BOG State Society Contacts Map: www.entnet.org/get-involved/board-of-governors/bog-state-society-contacts-map Project 535 (AAO-HNS member login required): www.entnet.org/project-535Note: Contributions to ENT PAC are not deductible as charitable contributions for federal income tax purposes. Contributions are voluntary, and all members of the American Academy of Otolaryngology–Head and Neck Surgery have the right to refuse to contribution without reprisal. Federal law prohibits ENT PAC from accepting contributions from foreign nationals. By law, if your contributions are made using a personal check or credit card, ENT PAC may use your contribution only to support candidates in federal elections. All corporate contributions to ENT PAC will be used for educational and administrative fees of ENT PAC, and other activities permissible under federal law. Federal law requires ENT PAC use its best efforts to collect and report the name, mailing address, occupation, and the name of the employer of individuals whose contributions exceed $200 in a calendar year. ENT PAC is a program of the AAO-HNS which is exempt from federal income tax under section 501 (c) (6) of the Internal Revenue Code.
-
Rahul K. Shah, MD, MBA, AAO-HNS/F Executive Vice President and CEO, travels to Albany ENT & Allergy Services in Albany, New York, to visit with AAO-HNS/F Past President Gavin Setzen, MD, and learn more about the unique model of care that serves the patient population in Albany. Dr. Setzen shares pearls and opportunities for practice success and how the Academy plays a role in that at all stages of one's career.
-
Rahul K. Shah, MD, MBA, talks with Shreya Mandava, MD, PGY1 Resident at the University of Michigan, about how she has found a passion for advocacy in her journey to otolaryngology. Dr. Mandava is the AAO-HNS Section for Residents and Fellows-in-Training delegate to the American Medical Association House of Delegates.
-
The new Voices of Otolaryngology with Rahul K. Shah, MD, MBA, podcast series is here to bring you exciting conversations and fresh perspectives from the individuals who comprise the depth and breadth of the specialty. Hosted by AAO-HNS/F EVP/CEO Rahul K. Shah, MD, MBA, this dynamic series takes a deep dive into the stories, goals, and innovations that are both impacting the current state of affairs in the house of medicine as well as shaping the future of the global otolaryngology community.
In this first episode, Dr. Shah is joined by the chairs of the Academy Sections: Annette M. Pham, MD, Chair of the Otolaryngology Private Practice Section (OPPS), Valerie A. Flanary, MD, Chair of the Women in Otolaryngology (WIO) Section, Mark A. Fadel, MD, JD, Chair of the Section for Residents and Fellows-in-Training (SRF), and James C. Wang, MD, PhD, Chair of the Young Physicians Section (YPS). Together, they share their bold visions, the challenges they’re eager to tackle, and the unique experiences they’re bringing to the table.
-
AAO-HNS/F At-Large Director Gene Brown, MD, RPh, AAO-HNS/F A explains the main elements of the Prior Authorization Final Rule and how it will help physicians handle prior authorization admin faster, provide more transparency, and improve patient care.
-
What's that nagging cough? Chronic cough is one of the most common reasons for patients to see a physician. Coughing interrupts sleep, producing fatigue and impairing concentration and work performance. In a new podcast commissioned by the Allergy, Asthma, and Immunology Committee, Christine Blanche Franzese, MD, Mark R. Gilbert, MD, and Thomas L. Carroll, MD, discuss the differential diagnosis for chronic cough as well as the work up. They also review various treatments for chronic cough and spend time discussing new treatments on the horizon for chronic cough.
-
Published literature on allergic rhinitis (AR) has expanded substantially in recent decades. This daunting amount of new literature may be overwhelming for the busy clinician and contribute to inertia. Fortunately, the International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis was published in early 2023 and can help aid otolaryngologists in tackling this formidable mountain of evidence. In this podcast, commissioned by the AAO-HNS Allergy, Asthma, and Immunology Committee, Christopher Brook, MD, one of the ICAR: Allergic Rhinitis 2023 authors, interviews Sarah K. Wise, MD, ICAR: Allergic Rhinitis 2023 editor. Hear more about the new recommendations and topics in comparison to the previous ICAR: Allergic Rhinitis from 2018.
-
Join Gene Brown, MD, RPh, AAO-HNS/F At-Large Director and general otolaryngologist, and James Lin, MD, the Academy’s CPT Advisor and a neurotologist, as they engage in a robust podcast discussion on the Centers for Medicare & Medicaid Services implementation of code G2211. This is a new code that went into effect on January 1, 2024. Dr. Brown and Dr. Lin provide clinical examples that indicate when code G2211 may be utilized in an otolaryngology practice.
-
"The Mid-Career Female Otolaryngologist: Past Perspectives and Future Challenges," is second in a series presented by the Section for Women in Otolaryngology (WIO), and features Sarah K. Rapoport, MD, Minka L. Schofield, MD, Priya D. Krishna, MD, and Margo M. McKenna, MD. Hear women in mid-career discuss their accomplishments, challenges, and their direction for the future.
-
Commissioned by the Allergy, Asthma and Immunology Committee, Joshua M Levy, MD, MPH and Bruce K. Tan, MD discuss mechanisms and biomarkers of endotypes in chronic rhinosinusitis. Subjects covered by this podcast include identification of types of inflammation, geographic variations in endotypes, and methods utilized to address different endotypes.
-
Matthew W. Ryan, MD, and Cecelia Damask, DO, share their insights on clinical presentations, laboratory evaluations, and treatment options regarding immunodeficiencies, during the podcast, “Immunodeficiency,” which was commissioned by the Allergy, Asthma, and Immunology Committee.
-
The Women in Otolaryngology (WIO) Section hosted a podcast on well-being. Moderator, Sarah K. Rapoport, MD, is joined by Katherine L. Fedder, MD, Meha G. Fox, MD, and Samantha J. Hauff, MD, in a discussion among women otolaryngologists on work-life balance in various stages of their careers.
-
Matthew W. Ryan, MD, and Cecelia Damask, DO, share their insights on nasal polyp inflammation and consider which is more important, IgE or the Eosinophil, during the podcast, “IgE vs. Eosinophil,” which was commissioned by the Allergy, Asthma, and Immunology Committee.
-
Host James G. Naples, MD, interviews Bert W. O'Malley, MD, current President and CEO of the University of Maryland Medical Center, on how he achieved professional success and the factors that contributed to his accomplishments.
-
James “Whit” Mims, MD, and Joshua M. Levy, MD, MPH, share their insights on the clinical trials of various biologics for chronic rhinosinusitis with nasal polyps during the podcast, “What's Important from the CRSwNP Biologics Trials,” commissioned by the Allergy, Asthma, and Immunology Committee.
-
Host James G. Naples, MD, interviews Debara L. Tucci, MD, MS, MBA, Director of the National Institute on Deafness and Other Communication Disorders, on how she achieved professional success and the factors that contributed to her accomplishments.
-
Christine Franzese, MD, and Michael P. Platt, MD, share their insights on immunology involving chronic rhinosinusitis with nasal polyps during the podcast “CRS and Type 2 Inflammation” commissioned by the Allergy, Asthma, and Immunology Committee.
- Laat meer zien
